IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 114 filers reported holding IMMUNOVANT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,441,549 | +289.6% | 75,991 | +218.5% | 0.01% | +400.0% |
| Q1 2023 | $370,007 | +16.4% | 23,856 | -58.2% | 0.00% | 0.0% |
| Q3 2022 | $318,000 | +29.3% | 57,027 | -9.5% | 0.00% | – |
| Q2 2022 | $246,000 | -21.9% | 63,047 | +10.4% | 0.00% | – |
| Q1 2022 | $315,000 | -56.1% | 57,110 | -32.2% | 0.00% | -100.0% |
| Q4 2021 | $718,000 | +3.5% | 84,294 | +5.6% | 0.00% | 0.0% |
| Q3 2021 | $694,000 | +109.7% | 79,812 | +155.3% | 0.00% | – |
| Q2 2021 | $331,000 | +114.9% | 31,268 | +224.8% | 0.00% | – |
| Q1 2021 | $154,000 | – | 9,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
| Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
| Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
| Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
| MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
| EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
| MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |